Kevin Chow
Chief Executive Officer at Mitera Biosciences.
Earliest Form D on file: May 2026
Filed May 6, 2026
Mitera Biosciences
Placental protein therapy for transplant rejection
Biotech, Bellevue WA
Signed as Chief Executive Officer
Chief Executive Officer at Mitera Biosciences.
Earliest Form D on file: May 2026
Placental protein therapy for transplant rejection
Biotech, Bellevue WA
Signed as Chief Executive Officer